REGENXBIO Inc. (RGNX) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 6.39M | 30.34M | 29.73M | 21.36M | 89.01M | 21.21M | 24.2M | 22.3M | 15.62M | 22.21M | 28.91M | 19.98M |
| Revenue Growth % | -92.82% | 43% | 22.88% | -4.2% | 469.79% | -4.5% | -16.31% | 11.6% | -18.37% | -29.13% | 9.06% | -38.81% |
| Cost of Goods Sold | 11.07M | 5.93M | 61.83M | 9.11M | 3.44M | 6.32M | 12.39M | 14.63M | 8.46M | 15.57M | 12.39M | 9.47M |
| COGS % of Revenue | 173.22% | 19.54% | 207.94% | 42.67% | 3.86% | 29.78% | 51.19% | 65.62% | 54.17% | 70.11% | 42.84% | 47.43% |
| Gross Profit | -4.68M | 24.41M | -32.09M | 12.24M | 85.58M | 14.9M | 11.81M | 7.67M | 7.16M | 6.64M | 16.53M | 10.5M |
| Gross Margin % | -73.22% | 80.46% | -107.94% | 57.33% | 96.14% | 70.22% | 48.81% | 34.38% | 45.83% | 29.89% | 57.16% | 52.57% |
| Gross Profit Growth % | -105.47% | 63.86% | -371.74% | 59.75% | 1095.36% | 124.34% | -28.54% | -27.01% | -52.36% | -64.23% | 23.16% | -46.68% |
| Operating Expenses | 78.68M | 82.05M | 20.32M | 75.52M | 73.45M | 66.26M | 73.89M | 63.7M | 68.92M | 70.54M | 81.49M | 83.61M |
| OpEx % of Revenue | 1230.74% | 270.45% | 68.33% | 353.59% | 82.52% | 312.36% | 305.36% | 285.72% | 441.18% | 317.58% | 281.82% | 418.53% |
| Selling, General & Admin | 21.31M | 22.38M | 20.25M | 19.88M | 20.35M | 20.05M | 19.42M | 18.86M | 18.29M | 19.08M | 23.08M | 23.7M |
| SG&A % of Revenue | 333.27% | 73.77% | 68.12% | 93.09% | 22.86% | 94.52% | 80.27% | 84.57% | 117.08% | 85.89% | 79.83% | 118.63% |
| Research & Development | 57.34M | 59.61M | 56.1M | 55.59M | 53.09M | 50.38M | 54.43M | 44.82M | 50.66M | 51.35M | 58.18M | 59.89M |
| R&D % of Revenue | 896.9% | 196.5% | 188.68% | 260.29% | 59.64% | 237.48% | 224.94% | 201.02% | 324.31% | 231.15% | 201.23% | 299.77% |
| Other Operating Expenses | 36K | 54K | -1000K | 45K | 15K | -1000K | 37K | 29K | -34K | 118K | 220K | 26K |
| Operating Income | -83.36M | -57.64M | -52.41M | -63.28M | 12.13M | -51.37M | -62.08M | -56.04M | -61.76M | -63.9M | -64.96M | -73.11M |
| Operating Margin % | -1303.96% | -189.99% | -176.27% | -296.26% | 13.62% | -242.14% | -256.55% | -251.34% | -395.35% | -287.68% | -224.67% | -365.96% |
| Operating Income Growth % | -787.41% | -12.2% | 15.57% | -12.92% | 119.64% | 19.62% | 4.44% | 23.35% | 6.64% | -10.61% | 8.57% | -16.91% |
| EBITDA | -83.36M | -53.77M | -48.52M | -59.37M | 16.08M | -47.34M | -58.12M | -51.99M | -57.58M | -59.57M | -60.59M | -68.67M |
| EBITDA Margin % | -1303.96% | -177.23% | -163.2% | -277.98% | 18.07% | -223.18% | -240.18% | -233.17% | -368.6% | -268.17% | -209.55% | -343.76% |
| EBITDA Growth % | -618.36% | -13.56% | 16.5% | -14.21% | 127.93% | 20.52% | 4.08% | 24.3% | 7.09% | -11.04% | 10.23% | -14.67% |
| D&A (Non-Cash Add-back) | 0 | 3.87M | 3.89M | 3.9M | 3.96M | 4.02M | 3.96M | 4.05M | 4.18M | 4.33M | 4.37M | 4.43M |
| EBIT | -83.36M | -54.87M | -48.77M | -59.88M | 14.65M | -41.77M | -58.78M | -52.54M | -61.36M | -61.68M | -60.24M | -70.94M |
| Net Interest Income | 8.71M | -12.26M | -13.17M | -7.59M | -8.54M | -9.33M | -795K | -420K | -1.94M | 1M | -1.57M | -1.08M |
| Interest Income | 0 | 18K | 0 | 3.4M | 0 | 83K | 25K | 29K | 37K | 2.37M | 56K | 40K |
| Interest Expense | -8.71M | 12.28M | 13.17M | 10.99M | 8.57M | 9.42M | 820K | 449K | 1.97M | 1.36M | 1.62M | 1.12M |
| Other Income/Expense | -6.69M | -9.51M | -9.53M | -7.59M | -6.04M | 182K | 2.48M | 3.05M | -1.57M | 862K | 3.09M | 1.05M |
| Pretax Income | -90.05M | -67.15M | -61.94M | -70.87M | 6.08M | -51.19M | -59.6M | -52.99M | -63.33M | -63.04M | -61.87M | -72.06M |
| Pretax Margin % | -1408.59% | -221.34% | -208.32% | -331.81% | 6.83% | -241.28% | -246.3% | -237.67% | -405.39% | -283.8% | -213.97% | -360.72% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -152K | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.24% | 0% | 0% |
| Net Income | -90.05M | -67.15M | -61.94M | -70.87M | 6.08M | -51.19M | -59.6M | -52.99M | -63.33M | -62.89M | -61.87M | -72.06M |
| Net Margin % | -1408.59% | -221.34% | -208.32% | -331.81% | 6.83% | -241.28% | -246.3% | -237.67% | -405.39% | -283.12% | -213.97% | -360.72% |
| Net Income Growth % | -1580.37% | -31.19% | -3.93% | -33.75% | 109.61% | 18.61% | 3.67% | 26.47% | 5.02% | -4.93% | 18.04% | -5.69% |
| Net Income (Continuing) | -90.05M | -67.15M | -61.94M | -70.87M | 6.08M | -51.19M | -59.6M | -52.99M | -63.33M | -62.89M | -61.87M | -72.06M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.72 | -1.30 | -1.20 | -1.38 | 0.12 | -1.01 | -1.17 | -1.05 | -1.38 | -1.43 | -1.41 | -1.66 |
| EPS Growth % | -1533.33% | -28.71% | -2.56% | -31.43% | 108.7% | 29.37% | 17.02% | 36.75% | 14.29% | -3.62% | 23.78% | -5.06% |
| EPS (Basic) | -1.72 | -1.30 | -1.20 | -1.38 | 0.12 | -1.01 | -1.17 | -1.05 | -1.38 | -1.43 | -1.41 | -1.66 |
| Diluted Shares Outstanding | 52.43M | 51.75M | 51.69M | 51.48M | 51.43M | 50.87M | 50.8M | 50.6M | 45.73M | 44M | 43.95M | 43.53M |
| Basic Shares Outstanding | 52.43M | 51.75M | 51.69M | 51.48M | 51.36M | 50.87M | 50.8M | 50.6M | 45.73M | 44M | 43.95M | 43.53M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |